IBM's second-quarter miss looks like a timing issue rather than AI taking over software, with valuation offering support. Shares fell after management cited clients shifting capex to memory and hardware amid supply constraints and price hikes, plus poor execution on closing deals. It is a rare miss for CEO Arvind Krishna. The stock could be dead money for a while. x.com 

IBM looks attractive because investors are treating a timing slip like a demand collapse. x.com 

IBM trades at an AI premium with no real AI growth behind it. The company forecast only 1% growth yet more than doubled from $150 to over $320 on AI hype, while its AI business is effectively non-existent. Its Q2 earnings warning came from consulting and infrastructure, not software, and the stock has fallen back to its May level around $220. x.com  x.com  x.com 

IBM should re-rate over the medium to long term on two fronts: quantum computing, where the U.S. government is taking a stake, and a broader software re-rating as software is no longer seen purely as an AI loser. IBM also has a strong customer base and channels, with deep customer stickiness. x.com 

IBM has a quantum catalyst in a $10B five-year commitment and a big US government deal, plus AI and hybrid cloud tailwinds as watsonx and generative AI bookings run strong and enterprise automation accelerates. The stock is almost above its 200-day moving average with momentum increasing. Analysts have issued multiple buy upgrades, including DZ Bank at $295, with targets of $280-$340+, 12-30% above roughly $255, and earnings estimates are rising. x.com 

IBM is extremely expensive, and its latest announcement adds caution: enterprises are prioritizing hardware and memory purchases, which pressures software spending. Quantum computing is a distant option, software is too small a part of the business to drive upside, and the stock carries a significant Trump premium. The same shift supports even stronger conviction in semiconductors and memory. x.com 

IBM could reach a $2 trillion market cap as a sovereign AI play, per Hugh Hendry. Global banks refuse to trust unproven AI apps and want IBM's legacy structural safety, and it also offers a pure US foundry play on quantum computing; Hendry rates it a buy-and-hold long toward its 2012 highs near $210. x.com 

Hardware is squeezing software as enterprises redirect budgets to scarce servers, GPUs and storage, favoring semiconductors over software. IBM's Q2 revenue of $17.2B missed its $17.9B target, and its CEO said clients moved software and IT consulting budgets to secure rising-priced hardware. Microsoft, ServiceNow and Salesforce face near-term pressure while Dell and Micron benefit. Aehr Test's beat and raised guidance counter claims the chip cycle is dead. x.com 

IBM is a valuation trap, with a high-conviction sell target of $200 by December 2026 as its multiple compresses toward its historical average. It lags in AI and quantum, its premium P/E lacks the structural growth to justify it, and its CY26 EPS estimate of $12.35 is under threat. A macro slowdown could push enterprises to cut nice-to-have transformation projects, and missing hyped quantum milestones would speed a rerating as Google and Microsoft pull ahead. x.com  x.com 

IBM's fundamentals are catching up with its chart after the market panicked over July earnings, setting up a potential gap fill. Since then IBM secured a $240M Nvidia-powered cluster deal with Together AI, partnered with OpenAI and bought DataStax. The stock has recovered from its $199 low and is testing heavy resistance at $241 near its 50-day EMA; a break and hold above $242 would leave the gap above wide open. x.com